InsidersTradesSigma
한국파마 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 한국파마 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 한국파마 has recorded 56 insider filings. Market capitalisation: €81.8bn. The latest transaction was filed on 28 May 2026 (Other). Among the most active insiders: 박은희. All data is accessible without an account.
54
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,643 of 28,065 companies
24.1
score / 100
Value24
Quality24
FCF yld1.6%
Earn yld-3.1%
EV/EBITDA56.2x
ROE-3.5%
Gross mgn36%
Net mgn-3.0%
Debt/EBITDA17.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 May 2026
Declarations56 total
Other
Other(filed)
Other
Other(filed)
25 of 56 declarations
About 한국파마
한국파마 is a company specializing in the health and pharmaceutical sector. It is listed on the XKRX market.